Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 133,680 shares at $50.20 ($6.7M) on 2020-10-07, disclosed to the SEC on 2020-10-08.
Open-market sale of $6.7M ADPT by CEO and Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.99 | 10,178 | $499K | 7.4% |
| 2 | $48.99 | 10,178 | $499K | 7.4% |
| 3 | $49.83 | 8,102 | $404K | 6.0% |
| 4 | $49.83 | 8,102 | $404K | 6.0% |
| 5 | $49.40 | 1,200 | $59K | 0.9% |
| 6 | $50.20 | 48,800 |
| $2.4M |
| 36.6% |
| 7 | $50.56 | 22,860 | $1.2M | 17.3% |
| 8 | $50.56 | 22,860 | $1.2M | 17.3% |
| 9 | $51.37 | 1,400 | $72K | 1.1% |
| Total | $50.10 avg | 133,680 | $6.7M | 100% |
| Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-03 | $8.3M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |